This document compiles frequently‑asked questions on data processing, standard curve fitting, anomaly troubleshooting, result interpretation and reporting specifications for quantitative and qualitative ELISA assays. It follows practical laboratory standards, supports beginners and experimental review, unifies criteria for data processing and result judgment, and helps avoid common experimental errors and misinterpretations.
In ELISA experiments, many researchers confuse qualitative ELISA with quantitative ELISA, leading to improper kit selection, result interpretation bias and redundant workflows. Though both are based on the core principle of antigen‑antibody specific binding, they differ significantly in experimental purpose, workflow, output format and application scenarios. This document compiles frequently‑asked questions from scientific research, clinical testing and inspection industries to address core concerns of qualitative and quantitative ELISA.
ELISA is the most commonly used quantitative detection technique in biological experiments and clinical testing. The accuracy and reproducibility of experimental results highly depend on standardized sample addition procedures and controlled incubation conditions. Most issues in ELISA experiments, such as false positives, false negatives, numerical deviations, and large inter-well differences, are not due to reagent quality but result from improper control of three core details: temperature, time, and light protection.
ELISA blocking is a crucial step in the enzyme-linked immunosorbent assay, and the effectiveness of blocking directly determines the experimental background, signal-to-noise ratio, and the reliability of the final data. In practical experiments, many people encounter various issues in selecting the blocking solution, setting incubation conditions, and troubleshooting abnormal results.
ELISA is a fundamental immunoassay technique widely used in biological experiments, scientific research testing and clinical laboratory diagnosis. Beginners often get confused about its principles, workflows, classifications, detection range and other basic concepts. This article organizes core ELISA knowledge in a FAQ format to cover common blind spots and help novice researchers quickly master key points of ELISA.
Coating is the fundamental core step of ELISA experiments. Essentially, it immobilizes specific antibodies or antigens onto the surface of a solid‑phase carrier to build an exclusive antigen‑antibody reaction platform. The quality of coating directly determines the sensitivity, specificity and reproducibility of the whole assay. Many abnormal ELISA results originate from improper coating operations. This FAQ document sorts out principles of coating, key influencing factors, blocking procedures, and the differences between in‑house coated plates and commercial pre‑coated kits, to help researchers troubleshoot common coating‑related experimental problems.
This article organizes FAQs for high-frequency issues in double-antibody sandwich ELISA experiments, covering pre-experiment preparation, complete operational points, data processing, and common fault analysis. It aims to help experimenters quickly identify problems, standardize experimental procedures, reduce experimental failures, and obtain stable and reliable detection data.
This article describes the optimization procedures for each detection component, ranging from capture antibodies to the selection of enzyme conjugates and substrates. Although each component is described individually, two components can be optimized simultaneously by performing a checkerboard titration in many cases.
Enzyme-Linked Immunosorbent Assay (ELISA), a classic immunoassay technique in life science research and clinical diagnosis, operates on the core principle of specific antigen-antibody binding reactions. It immobilizes soluble antigens or antibodies on solid-phase carriers such as polystyrene microplates, and through signal amplification via enzyme-catalyzed substrate color development, it enables qualitative analysis and accurate quantification of trace target substances in liquid biological samples. With outstanding advantages including high sensitivity, strong specificity, standardized operating procedures, minimal sample usage, reproducible detection results, and compatibility with high-throughput testing, ELISA technology is widely applied in clinical pathogen detection, tumor marker screening, autoantibody detection, and quantitative analysis of biomolecules such as antigens, antibodies, and cytokines in basic research. It is an indispensable core detection method in both research and clinical settings.
